Loss of heterozygosity for distal markers on 22q in human gliomas.
Loss of constitutional heterozygosity as determined through the analysis of restriction-fragment-length polymorphism (RFLP) on tumoral and constitutional DNA has proven to be helpful to delimit the location of tumor-suppressor genes in the human genome. In malignant gliomas this approach indicates that chromosomes 9p, 10, 17p, and 22 may contain genes of this category involved in its origin and/or progression. Regarding chromosome 22, the data so far provided by molecular studies confirmed those previously reported by cytogenetic studies, suggesting the existence of a sub-group of malignant gliomas characterized by monosomy of this chromosome. However, the precise location of the putative glioma suppressor gene on chromosome 22 remains ambiguous. We have performed a combined cytogenetic and RFLP study on a series of 31 gliomas, looking for structural abnormalities of this chromosome. In 3 instances, terminal deletions of the long arm of chromosome 22 were observed by both methodologies, suggesting that the band q13 region distal to the D22S80 marker might be the critical domain non-randomly involved in tumor suppression of gliomas.
Instituto de Investigaciones Biomédicas (CSIC); Madrid, Spain.
J A
JA
Rey
M J
MJ
Bello
A M
AM
Jimenez-Lara
J
J
Vaquero
M E
ME
Kusak
J M
JM
de Campos
J L
JL
Sarasa
A
A
Pestaña
D001254:Astrocytoma / Q000235:genetics; D001345:Autoradiography; D002872:Chromosome Deletion; D004273:DNA, Neoplasm / Q000032:analysis; D016147:Genes, Tumor Suppressor; D005819:Genetic Markers; D005910:Glioma / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D012150:Polymorphism, Restriction Fragment Length
D004273:DNA, Neoplasm; D005819:Genetic Markers